Literature DB >> 12767479

Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential.

Caroline Sievers1, Nick Platt, V Hugh Perry, Michael P Coleman, Laura Conforti.   

Abstract

Wallerian degeneration, the disintegration of the distal part of an injured axon, is an important event in many neurodegenerative diseases. We studied Wallerian degeneration in dorsal root ganglion (DRG) explants in culture by separating neurites from their cell bodies with a scalpel. The severed neurites showed Annexin V positive staining, that spreads distally with a rate comparable to that of slow axonal transport in intact neurons in vivo. Moreover, the injured neurites showed loss of mitochondrial membrane potential. These features resemble those seen when cells undergo apoptosis. These data contribute to a new understanding of the mechanism of axonal degeneration, have implications for the response of stromal cells in central nervous system (CNS) and raise the prospect of new pharmacological treatments for those neurodegenerative pathologies where the protection of the cell body alone does not alleviate the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767479     DOI: 10.1016/s0168-0102(03)00039-7

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  32 in total

Review 1.  Ca2+ signals and death programmes in neurons.

Authors:  Laura Berliocchi; Daniele Bano; Pierluigi Nicotera
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Sensory neuropathy attributable to loss of Bcl-w.

Authors:  Stephanie L Courchesne; Christoph Karch; Maria F Pazyra-Murphy; Rosalind A Segal
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

3.  Consequences of neurite transection in vitro.

Authors:  Nurettin Cengiz; Gürkan Oztürk; Ender Erdoğan; Aydın Him; Elif Kaval Oğuz
Journal:  J Neurotrauma       Date:  2012-09-27       Impact factor: 5.269

4.  WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.

Authors:  Michelle A Avery; Timothy M Rooney; Jignesh D Pandya; Thomas M Wishart; Thomas H Gillingwater; James W Geddes; Patrick G Sullivan; Marc R Freeman
Journal:  Curr Biol       Date:  2012-03-15       Impact factor: 10.834

5.  Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process.

Authors:  Mohammadali Almasieh; Maria-Magdalena Catrinescu; Loïc Binan; Santiago Costantino; Leonard A Levin
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

6.  Axonal Degeneration Is Mediated by Necroptosis Activation.

Authors:  Macarena S Arrázola; Cristian Saquel; Romina J Catalán; Sebastián A Barrientos; Diego E Hernandez; Nicolás W Martínez; Alejandra Catenaccio; Felipe A Court
Journal:  J Neurosci       Date:  2019-03-08       Impact factor: 6.167

7.  Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.

Authors:  Shota Kobayashi; Akiko Muroyama; Hiroaki Matsushima; Ikuo Yoshimura; Yasuhide Mitsumoto
Journal:  Neurol Sci       Date:  2011-05-20       Impact factor: 3.307

8.  Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.

Authors:  Brandon M Kitay; Ryan McCormack; Yunfang Wang; Pantelis Tsoulfas; R Grace Zhai
Journal:  Hum Mol Genet       Date:  2013-01-11       Impact factor: 6.150

9.  Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.

Authors:  Daniel W Summers; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

10.  Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.

Authors:  Jianyuan Wu; Qingdi Quentin Li; Huiping Zhou; Yinying Lu; Jueli M Li; Yao Ma; Li Wang; Tingting Fu; Xingjiang Gong; Michael Weintraub; Shuangchan Wu; Hong Ding
Journal:  Med Oncol       Date:  2014-06-01       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.